The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Kanwal Raghav
13:22
13:22
Afspil senere
Afspil senere
Lister
Like
Liked
13:22
Dr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled, ‘Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a randomised, multicentre, phase 2 trial’.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02)
13:22
13:22
Afspil senere
Afspil senere
Lister
Like
Liked
13:22
Dr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled, ‘Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a randomised, multicentre, phase 2 trial’. Read the full article: https://ww…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Emmy Boerrigter
11:41
11:41
Afspil senere
Afspil senere
Lister
Like
Liked
11:41
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Emmy Boerrigter on dose selection of novel anticancer drugs
11:41
11:41
Afspil senere
Afspil senere
Lister
Like
Liked
11:41
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00134-7?dgcid=buzzsprout_icw_podcast_generic_lan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Hisham Mehanna and Sue Yom
36:56
36:56
Afspil senere
Afspil senere
Lister
Like
Liked
36:56
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations
36:56
36:56
Afspil senere
Afspil senere
Lister
Like
Liked
36:56
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints. Tell us what you thought about this episode Continue this conversation on social! F…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Garth Strohbehn and Katie Lichter
24:08
24:08
Afspil senere
Afspil senere
Lister
Like
Liked
24:08
Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment
24:08
24:08
Afspil senere
Afspil senere
Lister
Like
Liked
24:08
Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it. Tell us what you thought about this episode Continue this conversatio…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... James Shultz, Ana Patricia Ortiz, and Leticia Nogueira
35:05
35:05
Afspil senere
Afspil senere
Lister
Like
Liked
35:05
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Personal View entitled, ‘Protecting Caribbean patients diagno…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean
35:05
35:05
Afspil senere
Afspil senere
Lister
Like
Liked
35:05
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Personal View entitled, ‘Protecting Caribbean patients diagno…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Bernardo Goulart
11:22
11:22
Afspil senere
Afspil senere
Lister
Like
Liked
11:22
Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials
11:22
11:22
Afspil senere
Afspil senere
Lister
Like
Liked
11:22
Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00040-8/fulltext?dgcid=buzzsprout_…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Maria Kyrgiou
25:42
25:42
Afspil senere
Afspil senere
Lister
Like
Liked
25:42
In a special episode on International Women's Day 2024, we speak with Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Maria Kyrgiou on innovations in gynaecological cancers and global disparities
25:42
25:42
Afspil senere
Afspil senere
Lister
Like
Liked
25:42
In a special episode on International Women's Day 2024, we speak with Dr Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Georgios Lyratzopoulos
34:43
34:43
Afspil senere
Afspil senere
Lister
Like
Liked
34:43
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
34:43
34:43
Afspil senere
Afspil senere
Lister
Like
Liked
34:43
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia. Tell us what you thought about this episode Continue this conversation on social! Follow us tod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Mike Sathekge
16:06
16:06
Afspil senere
Afspil senere
Lister
Like
Liked
16:06
Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer
16:06
16:06
Afspil senere
Afspil senere
Lister
Like
Liked
16:06
Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’ Read the full article: https://www.thelancet.com/journals/lanonc/article/…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
13:53
13:53
Afspil senere
Afspil senere
Lister
Like
Liked
13:53
Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma. Tell us what you thought about this episode Continue this con…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Shankar Siva
13:53
13:53
Afspil senere
Afspil senere
Lister
Like
Liked
13:53
Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Neerja Bhatla on a new quadrivalent HPV vaccine
12:24
12:24
Afspil senere
Afspil senere
Lister
Like
Liked
12:24
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India. Read the full article: https://www.thelancet.com/journals/la…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Neerja Bhatla
12:24
12:24
Afspil senere
Afspil senere
Lister
Like
Liked
12:24
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery
43:49
43:49
Afspil senere
Afspil senere
Lister
Like
Liked
43:49
Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https:…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Chandra Are
43:49
43:49
Afspil senere
Afspil senere
Lister
Like
Liked
43:49
Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Philipp Karschnia
17:10
17:10
Afspil senere
Afspil senere
Lister
Like
Liked
17:10
Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma
17:10
17:10
Afspil senere
Afspil senere
Lister
Like
Liked
17:10
Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma. Read the full Policy Review: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2…
…
continue reading
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Wanda Cui on measuring ovarian toxicity
10:37
10:37
Afspil senere
Afspil senere
Lister
Like
Liked
10:37
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00390-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Tell us what you thought abo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ticiana Leal on Tumour Treating Fields
9:01
9:01
Afspil senere
Afspil senere
Lister
Like
Liked
9:01
Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00344-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Tell us what you thought about this episode Continue this conversation on …
…
continue reading
Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Xuesong Han
12:31
12:31
Afspil senere
Afspil senere
Lister
Like
Liked
12:31
Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA
12:31
12:31
Afspil senere
Afspil senere
Lister
Like
Liked
12:31
Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00293-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Tell us wh…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
33:50
33:50
Afspil senere
Afspil senere
Lister
Like
Liked
33:50
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00246-2/fulltext?dgcid…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Carlos Fernández de Larrea and Damian Green
33:50
33:50
Afspil senere
Afspil senere
Lister
Like
Liked
33:50
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Madeline Pe
14:01
14:01
Afspil senere
Afspil senere
Lister
Like
Liked
14:01
Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Madeline Pe on the SISAQOL initiative
14:01
14:01
Afspil senere
Afspil senere
Lister
Like
Liked
14:01
Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative. Read the full article: https://www.thelancet.com/journals/lanonc/article/P…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Kadia Petricca and Joyce Kambugu
28:40
28:40
Afspil senere
Afspil senere
Lister
Like
Liked
28:40
Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children
28:40
28:40
Afspil senere
Afspil senere
Lister
Like
Liked
28:40
Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”. Read the full…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In Conversation With... Mark Lythgoe
14:11
14:11
Afspil senere
Afspil senere
Lister
Like
Liked
14:11
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mark Lythgoe on UK oncology drug approval after Brexit
14:11
14:11
Afspil senere
Afspil senere
Lister
Like
Liked
14:11
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit". Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Janet Brown
20:43
20:43
Afspil senere
Afspil senere
Lister
Like
Liked
20:43
Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Janet Brown on the phase 2/3 STAR trial
20:43
20:43
Afspil senere
Afspil senere
Lister
Like
Liked
20:43
Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma. Read the full article: Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cel…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Valerie Speirs on biomarkers in male breast cancer
17:40
17:40
Afspil senere
Afspil senere
Lister
Like
Liked
17:40
Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer. Read the full article: Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cance…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Valerie Speirs
17:40
17:40
Afspil senere
Afspil senere
Lister
Like
Liked
17:40
Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Sameer Bakhshi
23:02
23:02
Afspil senere
Afspil senere
Lister
Like
Liked
23:02
Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sameer Bakhshi on sex disparities in childhood cancer in India
23:02
23:02
Afspil senere
Afspil senere
Lister
Like
Liked
23:02
Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India. Read the full article: Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis Tell us what you thought about this episode Continue this conversation on social! …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Shankar Siva on radiotherapy for primary renal cell carcinoma
8:30
8:30
Afspil senere
Afspil senere
Lister
Like
Liked
8:30
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma. Read the full article: 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma Tell us what you thought about this episode …
…
continue reading
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.Af The Lancet
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mark Lawler and Richard Sullivan on the European Groundshot
23:20
23:20
Afspil senere
Afspil senere
Lister
Like
Liked
23:20
Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
In conversation with... Mark Lawler and Richard Sullivan
23:20
23:20
Afspil senere
Afspil senere
Lister
Like
Liked
23:20
Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission.Af The Lancet
…
continue reading